Conflict of interest: None declared.

Introduction and rationale {#ijs12571-sec-0007}
==========================

In the United States, stroke disproportionally affects minority populations [1](#ijs12571-bib-0001){ref-type="ref"}, [2](#ijs12571-bib-0002){ref-type="ref"}. Secondary prevention strategies in minority populations have been suboptimal due to cultural and behavioral factors not addressed in standard prevention modalities and poor integration into community resources [3](#ijs12571-bib-0003){ref-type="ref"}, [4](#ijs12571-bib-0004){ref-type="ref"}. Current practices, with decreased length of stay and rushed discharges, fail to reinforce the 'warning nature' of nondisabling transient ischemic attacks (TIAs)/mild strokes [5](#ijs12571-bib-0005){ref-type="ref"}, [6](#ijs12571-bib-0006){ref-type="ref"}. These practices reinforce the poor risk perception that many TIA/mild stroke patients associate with mild or resolved deficits [5](#ijs12571-bib-0005){ref-type="ref"}, [7](#ijs12571-bib-0007){ref-type="ref"}. Intensive, interactive, and culturally tailored discharge education strategies based on health promotion theory may improve accuracy of risk perception and promote behavior change.

Methods {#ijs12571-sec-0008}
=======

Design {#ijs12571-sec-0009}
------

The Discharge Educational Strategies for Reduction of Vascular Events (DESERVE) study is a prospective, randomized, multicenter trial of a novel, patient‐paced discharge behavioral intervention. The interactive, culturally tailored intervention focuses on acquisition of three skills‐based areas: risk knowledge, medication adherence, and patient--physician communication. The primary aim is to evaluate the efficacy of the behavioral intervention vs. standard discharge care on vascular risk reduction among racially/ethnically diverse TIA/mild stroke patients at 12 months postdischarge. We hypothesize that those randomized to the discharge intervention will have lower follow‐up systolic blood pressure (SBP) compared with usual care.

Patient population {#ijs12571-sec-0010}
------------------

Study patients are prospectively identified through daily screening of potential TIA/stroke cases at four urban medical centers with a high percentage of African American and Hispanic patients. This process includes daily review of stroke admissions and consultations, participation in rounds, and an emergency department notification pager. Patients with stroke, TIA, or stroke‐like symptoms are screened by study neurologists to confirm eligibility. Eligible patients are approached to obtain written informed consent.

Inclusion criteria {#ijs12571-sec-0011}
------------------

Presentation/transfer to enrolling site with one of the following diagnoses:TIAIschemic stroke (IS) with National Institutes of Health Stroke Scale (NIHSS) \<5 at enrollmentIntracerebral hemorrhage (ICH) with NIHSS \<5 at enrollmentAge \>18 yearsNew York area resident with phoneOne or more vascular risk factors:HyperlipidemiaHypertensionCurrent smokerDiabetes mellitus, type 2Metabolic syndromeCan participate in educational sessions in English or Spanish

Exclusion criteria {#ijs12571-sec-0012}
------------------

Discharged to nursing home or requiring 24‐hour in‐home careBaseline modified Rankin score (mRS) of \>2DementiaEnd‐stage disease with life expectancy less than one‐year

Randomization {#ijs12571-sec-0013}
=============

Subjects are randomized, stratified for language, into intervention or usual care groups in a 1:1 ratio using a computerized permuted block randomization program (Table [1](#ijs12571-tbl-0001){ref-type="table-wrap"}).

###### 

Intervention summary

                        Baseline             Discharge                                               72 h                                                                          One‐month                                                                                                                                      Three‐months                                                                                                          Six‐months                                                        12 months
  --------------------- -------------------- ------------------------------------------------------- ----------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------- -----------------------------------------------------------------
  Intervention group    Baseline interview   Educational PowerPoint PresentationMotivational Video   Poststroke contact formDelivery of workbookVerify follow‐up doctor\'s visit   One‐month follow‐up formReminder about doctor\'s visitReview patient/physician communication in workbookFollow‐up call after doctor\'s visit   Three‐month follow‐up formFollow‐up other doctor\'s visitsReview main components of workbookDiscuss other resources   In‐person visit/formBP, HbA1c, AnthopometricsRe‐review workbook   In‐person visit/formBP, HbA1c, AnthopometricsRe‐review workbook
  Standard care group   Baseline interview   Standard discharge education                            Patient‐guided contact                                                        Patient‐guided contact                                                                                                                         Patient‐guided contact                                                                                                In person visit/formBP, HbA1c, Anthopometrics                     In‐person visit/formBP, HbA1c, Anthopometrics

BP, blood pressure; HbA1c, glycated hemoglobin.
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Study arms {#ijs12571-sec-0014}
----------

All patients receive a baseline interview including questions on demographics, social resources, health literacy, medication adherence, and validated measures of stroke knowledge/preparedness [5](#ijs12571-bib-0005){ref-type="ref"}, [8](#ijs12571-bib-0008){ref-type="ref"}. Baseline SBP, anthropometric measures, glycated hemoglobin (HbA1c), and lipid panel are measured. Charts are abstracted for additional history and clinical information. All participants receive a bag containing a tape measure to monitor waist circumference and a pillbox to organize medications.

All participants are followed up in‐person at 6 and 12 months postdischarge. At each in‐person assessment study, health workers conduct a brief structured interview to determine changes in stroke risk factors, risk behaviors, medication compliance, social support status, quality of life, and physical activity scale. Measurements of SBP, HbA1c, and anthropometric indices are repeated.

Intervention {#ijs12571-sec-0015}
------------

Patients randomized to intervention engage in an educational session with a community health worker (CHW) and watch a culturally tailored motivational video of stroke survivorship narratives prior to discharge. Intervention patients receive a take‐home patientpaced, copy of the workbook (Figure [1](#ijs12571-fig-0001){ref-type="fig"}) and video (Figure [2](#ijs12571-fig-0002){ref-type="fig"}) comprised of interactive, skill‐based modules emphasizing DESERVE\'s three thematic areas: patient--physician communication, medical adherence, and accurate risk perception. In addition to the 6‐ and 12‐month follow‐ups for all subjects, intervention subjects receive calls scheduled at key intervals from CHWs to motivate behavior change, promote access to resources, and provide social support.

![Informational and motivational presentation on stroke pathophysiology, risk factors, and lifestyle modification. (a) Graphic demonstration of increased risk after initial ischemic event; (b) graphic demonstration on empowering patients at doctors\' visits.](IJS-10-151-g001){#ijs12571-fig-0001}

![Motivational video (a) 'I Had No Idea': Patients describe their initial stroke and inaccurate assessment of vascular risk. (b) The Spanish version is culturally tailored to notions of faith and community. (c) 'Don\'t Give Up': Patients provide motivation in their own words: 'Please don\'t give up, and above all, put in your heart that pity don\'t live there'. (d) 'Keep on the Plan': patients advise on how to be proactive at doctors\' visits.](IJS-10-151-g002){#ijs12571-fig-0002}

The DESERVE intervention is rooted in the Transtheoretical Model (TTM) for behavioral change. TTM emphasizes 'stages of change' as the pathway for sustainable behavior change. We posit the TIA/mild stroke 'teachable moment' propels the stroke survivor to the preparation stage for risk‐reduction strategies. Data from the Stroke Warning Information and Faster Treatment (SWIFT) trial provides evidence that patients and family members request action steps to address risk reduction [4](#ijs12571-bib-0004){ref-type="ref"}. The DESERVE intervention utilizes the key TTM process of self‐evaluation to continue to identify realistic, rational ways to change behavior and incorporate the changes into a new self‐identity.

The DESERVE intervention also employs constructs from the Chronic Care Model (CCM), including community‐based interventions, to improve care integration [9](#ijs12571-bib-0009){ref-type="ref"}, [10](#ijs12571-bib-0010){ref-type="ref"}. Utilizing CCM in medically underserved communities is critical in addressing complex issues within communities. DESERVE utilizes bilingual CHWs to maximize cultural congruence in the intervention which is specifically tailored to minority TIA/mild stroke survivors.

Usual care {#ijs12571-sec-0016}
----------

Usual care includes standard stroke care and treatment and distribution of standard stroke pamphlets in English or Spanish from the American Heart Association. Usual care subjects are given study contact information in case they have further questions. Any phone calls initiated by study participants will be documented.

Primary outcome {#ijs12571-sec-0017}
---------------

The primary outcome is difference in SBP reduction between the intervention and standard care arms in mmHg at 12‐month follow‐up.

Secondary outcomes {#ijs12571-sec-0018}
------------------

Secondary outcomes include between‐group differences in reduction of other vascular risk factors: HbA1c, body mass index (BMI), waist circumference, and smoking. Additionally, between‐group differences in medication adherence, appropriate self‐assessment of stroke risk, and medical appointment compliance will be assessed. We will also perform an analysis looking at the incremental cost of the intervention based on the average time spent by each health worker on each intervention patient times an expected cost per time unit. We will then compare this cost with other methods of blood pressure control.

Data and safety monitoring {#ijs12571-sec-0019}
==========================

While a data and safety monitoring plan was not required for this low‐risk educational intervention, protocols were established for cases where severe BP elevations or depression were detected during follow‐up.

Sample size {#ijs12571-sec-0020}
===========

A randomized pilot study of 50 TIA/mild stroke patients demonstrated an 8 mmHg reduction in SBP in the intervention vs. standard care group. We then conducted power analysis using a lower 6 mmHg estimate of SBP change and an assumed variability of 23 mmHg as seen in the pilot study. Given 300 subjects per group and α = 0·05, power is 89·1%.

Statistical analysis {#ijs12571-sec-0021}
--------------------

We will utilize two‐sample *t*‐tests in an intent‐to‐treat analysis for the primary outcome. We will evaluate the association between intervention assignment and change in SBP using linear regression controlling for relevant confounders including language. We will conduct repeated measures analysis using the changes in SBP at 6 and 12 months as a vector of outcome. We will fit a generalized estimating equation (GEE) model using the intervention indicator, time, and interaction between the intervention indicator and time as covariates. We will utilize multiple imputation for missing data in the intention‐to‐treat analysis.

Study organization and funding {#ijs12571-sec-0022}
------------------------------

NIH P50‐NS049060 to Dr. Boden‐Albala. The trial was registered at [clinicaltrials.gov](http://clinicaltrials.gov) (\#NCT 01836354).

Discussion {#ijs12571-sec-0023}
==========

DESERVE will assess whether a novel, patient‐paced, culturally tailored education intervention can facilitate reduced vascular risk factors in survivors of mild stroke/TIA in a diverse, urban population. This intervention goes beyond typical lifestyle modification programs of diet and exercise and utilizes a theoretical construct to aid behavior change. We have made special considerations for commitment to family, communalism, religion/spirituality, fatalism, mistrust, worry about isolation, and death. Importantly, the DESERVE intervention is based on numerous pilot studies integrating input from African American and Latino stroke survivors and their family members, ethnically diverse community focus groups, community health advocates, and key community leaders. By utilizing patient‐paced workbooks and videos, we hope to make these interventions sustainable and practical in nonstudy settings with often limited resources.
